AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
TOP Financial (TOP) Prnewswire·2025-03-08 19:00TOP Financial (TOP) Prnewswire·2025-03-08 19:00
R1TOP Financial (TOP) Prnewswire·2025-03-08 19:00